https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-01 / Expert Rev Vaccines 2006 Apr;5(2):211-22
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-01 / Expert Rev Vaccines 2006 Apr;5(2):211-222006-04-01 00:00:002019-02-15 08:32:40Current progress in the development of a cell-based vaccine for the immunotherapy of acute myeloid leukemia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-01 / Int. J. Oncol. 2006 Apr;28(4):855-61
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-01 / Int. J. Oncol. 2006 Apr;28(4):855-612006-04-01 00:00:002019-02-15 08:32:40Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blasts
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-01 / Expert Rev Vaccines 2006 Apr;5(2):233-47
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-01 / Expert Rev Vaccines 2006 Apr;5(2):233-472006-04-01 00:00:002019-02-15 09:00:02Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-01 / J Cancer Res Ther 2006 Apr-Jun;2(2):41-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-01 / J Cancer Res Ther 2006 Apr-Jun;2(2):41-62006-04-01 00:00:002019-02-15 09:17:42Hyperthermia today: electric energy, a new opportunity in cancer treatment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-01 / Leuk. Lymphoma 2006 Apr;47(4):675-82
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-01 / Leuk. Lymphoma 2006 Apr;47(4):675-822006-04-01 00:00:002006-04-01 00:00:00Autologous dendritic cells pulsed with eluted peptide as immunotherapy for advanced B-cell malignancies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-01 / Clin. Exp. Immunol. 2006 Apr;144(1):41-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-01 / Clin. Exp. Immunol. 2006 Apr;144(1):41-72006-04-01 00:00:002006-04-01 00:00:00Cancer immunotherapy using dendritic/tumour-fusion vaccine induces elevation of serum anti-nuclear antibody with better clinical responses
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-03-15 / Eur. Respir. J. 2006 Jun;27(6):1086-95
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-03-15 / Eur. Respir. J. 2006 Jun;27(6):1086-952006-03-15 00:00:002006-03-15 00:00:00Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-03-09 / Leuk. Res. 2006 Jul;30(7):785-94
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-03-09 / Leuk. Res. 2006 Jul;30(7):785-942006-03-09 00:00:002019-02-15 08:37:29Circulating myeloid dendritic cell directly isolated from patients with chronic myelogenous leukemia are functional and carry the bcr-abl translocation
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-03-07 / Ann. Hematol. 2006 May;85(5):308-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-03-07 / Ann. Hematol. 2006 May;85(5):308-142006-03-07 00:00:002019-02-15 09:25:36Peripheral blood mobilization of different lymphocyte and dendritic cell subsets with the use of intermediate doses of G-CSF in patients with non-Hodgkin’s lymphoma and multiple myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-03-03 / Biochem. Biophys. Res. Commun. 2006 Apr;343(1):269-78
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-03-03 / Biochem. Biophys. Res. Commun. 2006 Apr;343(1):269-782006-03-03 00:00:002019-02-15 08:48:22Immunization with heat shock protein 105-pulsed dendritic cells leads to tumor rejection in mice
